Navigation Links
NACCHO to Support Influenza Vaccination Efforts With Donation of Up to One Million Doses of FluMist(R)
Date:12/10/2008

WASHINGTON, Dec. 10 /PRNewswire/ -- The National Association of County and City Health Officials (NACCHO) today announced a donation of up to one million doses of FluMist(R) (Influenza Virus Vaccine Live, Intranasal) by MedImmune in a partnership aimed at increasing influenza awareness and vaccinations in underserved communities and populations.

NACCHO will make these donated doses of vaccine available to selected state and local health departments around the country starting this month. This joint NACCHO-MedImmune effort supports the goal of the Centers for Disease Control and Prevention (CDC) to broaden the influenza vaccination season into December and beyond. The CDC has launched National Influenza Vaccination Week (December 8-12) as a springboard to help educate the public on the importance of influenza vaccination throughout the winter. Vaccination rates typically decline after Thanksgiving, although the peak of influenza season usually occurs in February and March.

"NACCHO is pleased to partner with MedImmune to help increase the number of individuals vaccinated against influenza," said NACCHO President Gary Cox, J.D. "These doses of vaccine will go a long way to support a national objective of immunizing all persons who should receive flu vaccine, especially those who are least able to afford it."

Public health guidelines on annual influenza vaccination are broader than ever before. In February 2008, the CDC's Advisory Committee on Immunization Practices (ACIP) voted to expand pediatric influenza vaccination recommendations to include school-age children ages 5 through 18 years. The expanded recommendations add 30 million children to the recommended pediatric population for annual influenza vaccination. In addition to influenza vaccination recommendations for specific populations (http://www.cdc.gov/flu), the CDC recommends that anyone who wants to reduce their chances of getting influenza or spreading it to others get vaccinated every year.

"We are proud to support NACCHO's objective of increasing flu vaccination rates across the country," stated Brian Rosen, MedImmune's senior director, government relations. "We at MedImmune take great pride in knowing this donation may help protect up to one million more eligible men, women, and children against influenza, and educate them about the importance of protecting themselves and their families against influenza."

About NACCHO

NACCHO (National Association of County and City Health Officials) is the national organization representing the nation's nearly 3,000 local health departments. These agencies work every day on the front lines to protect and promote the health of their communities. NACCHO develops resources and programs and promotes national policies that support effective local public health practice. For additional information about NACCHO, visit: http://www.naccho.org.

About FluMist

FluMist is a live attenuated influenza virus vaccine indicated for active immunization of individuals two to 49 years of age against influenza disease caused by influenza virus subtypes A and type B contained in the vaccine.

FluMist is contraindicated in individuals with history of hypersensitivity to eggs, egg proteins, gentamicin, gelatin or arginine or with life-threatening reactions to previous influenza vaccinations, and in children and adolescents receiving concomitant aspirin or aspirin-containing therapy.

Do not administer FluMist to children less than two years of age due to an increased risk of hospitalization and wheezing that was observed in clinical trials. FluMist should not be administered to any individual with asthma and to children less than five years of age with recurrent wheezing unless the potential benefit outweighs the potential risk. Do not administer FluMist to individuals with severe asthma or active wheezing.

If Guillain-Barre syndrome has occurred with prior influenza vaccination or if an individual is immunocompromised, the decision to give FluMist should be based on careful consideration of the potential benefits and risks. FluMist should not be administered to individuals with underlying medical conditions predisposing them to wild-type influenza infection complications unless the potential benefit outweighs the potential risk. FluMist should be given to a pregnant woman only if clearly needed.

Most common adverse reactions (occurring in 10 percent or more of individuals receiving FluMist and at a rate at least five percent higher than in those receiving placebo) are runny nose or nasal congestion in recipients of all ages, fever more than 100 degrees F in children two to six years of age, and sore throat in adults.

FluMist may not protect all individuals receiving the vaccine. FluMist is for intranasal administration only.

Please see complete Prescribing Information for FluMist, available by calling 1-877-FLUMIST (1-877-358-6478) or visiting http://www.medimmune.com/pdf/products/flumist_pi.pdf for additional information.


'/>"/>
SOURCE NACCHO
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. AT&T Supports the Smith Familys Learning For Life Program
2. American Lung Association Announces Support of Pickens Plan
3. Video: Childhood Influenza Immunization Coalition Supports Second Annual Childrens Flu Vaccination Day
4. Upsher-Smith Laboratories Launches Prenexa.com to Support Prenatal Nutrition and Health
5. Turn to Diabetic Care Services for Personalized Support and Hassle-Free Diabetes Supplies
6. Long Term Care Sector Supports and Is Well-Positioned to Advance Health Care Reform, Bolster Economic Stimulus
7. Over 40 Hospitals Lend Support for Individual Insurance Market Reform
8. Medicsight PLC Presents New Data at RSNA 2008 Further Supporting Relevance of Computer-Aided Detection (CAD) and Image Analysis Software in Early Colon Cancer Screening and Diagnosis
9. International study supports new standard of treatment for women with advanced ovarian cancer
10. MEDai Evidence-Based Guideline Reporting Provides Decision Support at Point of Care
11. Canada Supports Ground-Breaking Malaria Treatment Program in Sub-Saharan Africa
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... 13, 2017 , ... The International Association of Eating Disorders ... for the field of eating disorders, announces the opening of early registration for ... Florida at the Omni Resort at ChampionsGate. , The annual iaedp™ ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... PharmD ‘17, and Jennifer Huggins, PharmD ’17, along with clinical associate professor ... prevention of cardiovascular diseases during the 15th Annual Women’s Health Conference. The ...
(Date:10/13/2017)... ... 13, 2017 , ... Apple Rehab Shelton Lakes , which specializes in ... the facility as part of a disaster drill on October 3rd. , Apple Rehab ... City Emergency Manager, as well as the Connecticut Long Term Care Mutual Aid ...
(Date:10/13/2017)... ... October 13, 2017 , ... The Visiting Nurse Association (VNA) of Somerset ... of specialty vendors and unique items from across the nation, this holiday-themed event will ... services offered by the VNA. The boutique will be open Saturday, November 4 ...
(Date:10/13/2017)... ... October 13, 2017 , ... Global Healthcare Management’s 4th Annual Kids ... Milford, NJ. This free event, sponsored by Global Healthcare Management’s CEO, Jon Letko, ... run is geared towards children of all ages; it is a non-competitive, non-timed event, ...
Breaking Medicine News(10 mins):
(Date:10/4/2017)... , Oct. 4, 2017  South Korean-based healthcare ... CPR training aide "cprCUBE" on Kickstarter. The device will ... during cardiac arrests with better efficiency compared to the ... offers real-time feedback on efficacy of the compression for ... campaign has a goal to raise $5,000. ...
(Date:10/2/2017)... , Oct. 2, 2017 Diplomat Pharmacy, ... 8th Day Software and Consulting, LLC , and named ... 8th Day Software, based in Tennessee , ... 8th Day expands EnvoyHealth,s service offerings for health care ... "In an interoperable ...
(Date:10/2/2017)... Labs announces the European launch of their new low volume, high ... in Cambridge, U.K on October 4th. The ... with unprecedented speed and sensitivity while using far less sample volume ... ... ...
Breaking Medicine Technology: